Glypican-6 (GPC6) is a cell surface heparan sulfate proteoglycan that plays a crucial role in the regulation of morphogen signaling pathways critical for development and cell differentiation, such as Wnt, Hedgehog, and FGF pathways. Chemicals such as Lithium Chloride, BIO, and SB216763 activate the Wnt signaling pathway by inhibiting GSK-3β, which in the absence of Wnt ligands promotes the degradation of β-catenin, a key signal transducer in the pathway. By preventing this degradation, these chemicals can lead to the accumulation of β-catenin in the nucleus and the subsequent transcriptional activation of Wnt target genes, which includes glypicans. This indirect activation of GPC6 through Wnt signaling pathway enhancement suggests a potential elevation in GPC6 expression and function.
Similarly, Purmorphamine and SAG act on the Hedgehog signaling pathway by mimicking the effects of Hedgehog ligands, leading to the activation of the pathway and potentially an increase in GPC6 expression as part of the transcriptional response. Cholesterol and Cyclopamine, while having opposing roles in the Hedgehog pathway, underscore the complexity of pathway regulation and the potential for feedback mechanisms that could also indirectly modulate GPC6 activity. Forskolin, by increasing intracellular cAMP levels, could influence a range of signaling pathways, including those involving GPC6, by modulating protein kinase A (PKA) activity and downstream signaling events. Retinoic Acid may affect GPC6 by altering the differentiation state of cells, which is closely linked to the regulation and expression of proteoglycans.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride can indirectly increase GPC6 activity by inhibiting GSK-3β in the Wnt signaling pathway, which may lead to enhanced expression of GPC6. | ||||||
Purmorphamine | 483367-10-8 | sc-202785 sc-202785A | 1 mg 5 mg | $56.00 $180.00 | 18 | |
Purmorphamine activates the Hedgehog signaling pathway, which could indirectly increase GPC6 activity through upregulated expression. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $26.00 $2754.00 $126.00 $206.00 $572.00 $86.00 | 11 | |
Cholesterol is a component that can activate the Hedgehog signaling pathway; increased activity in this pathway can indirectly upregulate GPC6. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin raises cAMP levels, potentially enhancing the cellular signaling pathways in which GPC6 is involved, leading to increased activity of GPC6. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid may influence the expression of GPC6 by affecting the differentiation status of cells and possibly upregulating proteoglycans including GPC6. | ||||||
SAG | 912545-86-9 | sc-212905 sc-212905A | 1 mg 5 mg | $163.00 $413.00 | 27 | |
SAG activates the Hedgehog signaling pathway, potentially increasing the functional activity of GPC6 through enhanced expression. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
By inhibiting ROCK, Y-27632 could modulate the actin cytoskeleton and related signaling, possibly leading to an increase in GPC6 activity. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $57.00 $184.00 $867.00 | 10 | |
BIO, as a GSK-3 inhibitor, can activate the Wnt pathway, which could lead to increased GPC6 activity through upregulation of its expression. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
XAV-939 stabilizes Axin by inhibiting tankyrase, which may lead to the upregulation of GPC6 expression as Axin is involved in the Wnt signaling pathway. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
SB216763 inhibits GSK3, potentially increasing Wnt activity and thereby GPC6 activity through upregulation of Wnt target genes. |